Corrigendum: Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation

• Vinai Bhagirath,
• Tanya Kovalova,
• Jia Wang,
• Lizhen Xu,
• Shrikant I. Bangdiwala,
• Martin O'Donnell,
• Ashkan Shoamanesh,
• Jackie Bosch,
• Rosa Coppolecchia,
• Tatsiana Vaitsiakhovich,
• Frank Kleinjung,
• Hardi Mundl,
• John Eikelboom

Affiliations

Vinai Bhagirath

Population Health Research Institute, Hamilton, Ontario, Canada

Tanya Kovalova

Population Health Research Institute, Hamilton, Ontario, Canada

Jia Wang

Population Health Research Institute, Hamilton, Ontario, Canada

Lizhen Xu

Population Health Research Institute, Hamilton, Ontario, Canada

Shrikant I. Bangdiwala

Population Health Research Institute, Hamilton, Ontario, Canada

Martin O'Donnell

Population Health Research Institute, Hamilton, Ontario, Canada

Ashkan Shoamanesh

Population Health Research Institute, Hamilton, Ontario, Canada

Jackie Bosch

McMaster University, Hamilton, Ontario, Canada

Rosa Coppolecchia

Bayer US LLC, Whippany, New Jersey, United States

Tatsiana Vaitsiakhovich

Bayer AG, Berlin, Germany

Frank Kleinjung

Bayer AG, Berlin, Germany

Hardi Mundl

Bayer AG, Wuppertal, Germany

John Eikelboom

Population Health Research Institute, Hamilton, Ontario, Canada